Skip to content

Clinical trials

Completed Phase 4 Lupus Erythematosus, Systemic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Phase: Phase 4 Status: Completed Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20062
20073
20094
20101
20122
20132
20151
20162
20172
20214
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese University of Hong Kong3
Tuen Mun Hospital3
GlaxoSmithKline2
Human Genome Sciences Inc., a GSK Company2
Mallinckrodt2
RenJi Hospital2
University of Sao Paulo General Hospital2
Ampel BioSolutions, LLC1
Assistance Publique - Hôpitaux de Paris1
Guy's and St Thomas' NHS Foundation Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic27
Atherosclerosis4
Autoimmune Diseases3
Lupus Nephritis3
Glomerulonephritis2
Acquired Immunodeficiency Syndrome1
Arthritis, Juvenile1
Arthritis, Rheumatoid1
COVID-191
Dermatomyositis1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.